9534
T.D. Lash, V.R. Yant / Tetrahedron 65 (2009) 9527–9535
6.77 (2H, s), 6.99 (2H, dd, J¼1.7, 7.7 Hz), 7.17 (2H, d, J¼4.8 Hz), 7.29
(1H, t, J¼1.6 Hz), 734–7.37 (5H, m), 7.40–7.48 (12H, m), 10.26 (1H, br
J¼1.6 Hz), 7.26 (2H, d, J¼4.8 Hz, partially obscured by solvent peak),
7.40–7.49 (18H, m), 10.10 (1H, br s); 1H NMR (500 MHz, TFA–CDCl3):
s); 1H NMR (500 MHz, TFA–CDCl3):
d
5.43 (1H, t, J¼1.6 Hz), 7.12 (2H,
d
1.09 (9H, s), 5.18 (1H, t, J¼1.6 Hz), 7.10 (2H, dd, J¼1.5, 5.0 Hz), 7.20
dd, J¼1.5, 5.0 Hz), 7.19 (2H, dd, J¼1.6, 7.8 Hz), 7.28 (2H, d, J¼1.4 Hz),
7.50 (4H, d, J¼8.5 Hz), 7.54 (4H, br s, J¼7.0 Hz), 7.58–7.66 (6H, m),
7.68 (4H, d, J¼8.5 Hz), 7.79–7.83 (3H, m), 8.98 (1H, br s), 10.39 (2H,
(2H, d, J¼1.5 Hz), 7.25 (2H, d, J¼1.4 Hz), 7.52 (4H, br d, J¼7.9 Hz), 7.56–
7.60 (8H, m), 7.72 (4H, t, J¼7.9 Hz), 7.80–7.83 (2H, m), 7.84 (2H, dd,
J¼1.5, 5.0 Hz), 8.95 (1H, br s), 10.38 (2H, br s); 13C NMR (TFA–CDCl3):
br s); 13C NMR (TFA–CDCl3):
d
93.6, 117.2, 129.2, 129.5, 129.9, 130.8,
d 30.6, 35.4, 92.3,115.1,128.89,128.94,129.4,133.1,133.3,133.5,134.7,
133.3, 133.6, 134.1, 135.9, 136.1, 136.3, 137.8, 137.95, 138.02, 140.4,
144.4, 150.0, 152.3, 161.8; HRMS (EI), m/z calcd for C46H29Cl2N3þ2H:
695.1895. Found: 695.1884. Anal. calcd for C46H29Cl2N3$1/10CHCl3:
C, 78.36; H, 4.15; N, 5.95. Found: C, 78.29; H, 4.06; N, 5.86.
135.0, 135.5, 137.0, 137.9, 138.1, 139.9, 144.2, 152.0, 152.8, 156.5, 161.0;
HRMS (EI), m/z calcd for C50H37Cl2N3þ2H: 751.2521. Found:
751.2524. Anal. calcd for C50H37Cl2N3: C, 79.99; H, 4.97; N, 5.60.
Found: C, 79.97; H, 4.80; N, 5.56.
4.2.8. 6,11,16,21-Tetrakis(chlorophenyl)benziporphyrin (8d). Prepared
by the foregoing procedure from dicarbinol 10b (359 mg,
1.00 mmol), 4-chlorobenzaldehyde (281.2 mg, 2.00 mmol) and
4.2.11. 3-tert-Butyl-6,21-bis(4-chlorophenyl)-11,16-diphenylbenzi-
porphyrin (8g). Prepared by the foregoing procedure from dicar-
binol 10d (415 mg, 1.00 mmol), benzaldehyde (205
mL, 2.00 mmol)
pyrrole (208
mL, 3.00 mmol). Recrystallization from chloroform–
and pyrrole (208 L, 3.00 mmol). Recrystallization from chloro-
m
ligroin gave the benziporphyrin (183.5 mg, 0.240 mmol, 24%) as
dark green crystals, mp >300 ꢁC; UV–vis (1% Et3N–CHCl3): lmax
(log10 3) 416 (4.92), 690 (sh, 4.12), 730 nm (4.14); UV–vis (1% TFA–
CHCl3): lmax (log10 3) 336 (4.57), 387 (4.45), 466 (5.14), 627 (3.75),
form–ligroin gave the benziporphyrin (40.9 mg, 0.054 mmol, 5.4%)
as dark green crystals, mp >300 ꢁC; UV–vis (1% Et3N–CHCl3): lmax
(log10 3) 419 (4.96), 698 (sh, 4.11), 746 nm (4.14); UV–vis (1% TFA–
CHCl3): lmax (log10 3) 329 (4.57), 385 (4.42), 467 (5.19), 629 (3.72),
670 (3.75), 900 nm (4.26); 1H NMR (500 MHz, CDCl3):
d
6.54 (2H, d,
672 (3.71), 900 nm (4.29); 1H NMR (500 MHz, CDCl3):
d 1.03 (9H, s),
J¼4.8 Hz), 6.75 (2H, s), 6.99 (2H, dd, J¼1.7, 7.8 Hz), 7.19 (2H, d,
6.57 (2H, d, J¼4.8 Hz), 6.79 (2H, s), 6.98 (1H, t, J¼1.6 Hz), 7.03 (2H, d,
J¼4.8 Hz), 7.24 (1H, br t, J¼1.6 Hz), 7.33–7.46 (16H, m), 10.21 (1H, br
J¼1.6 Hz), 7.19 (2H, d, J¼4.8 Hz), 7.37 (4H, d, J¼8.4 Hz), 7.41–7.49
s); 1H NMR (500 MHz, TFA–CDCl3):
d
5.47 (1H, t, J¼1.6 Hz), 7.11 (2H,
(14H, m), 10.12 (1H, br s); 1H NMR (500 MHz, TFA–CDCl3):
d 1.12
dd, J¼1.5, 5.0 Hz), 7.19 (2H, dd, J¼1.7, 7.8 Hz), 7.26 (2H, d, J¼1.5 Hz,
obscured by solvent peak), 7.47–7.50 (8H, m), 7.58–7.60 (4H, m),
7.68–7.71 (4H, m), 7.80–7.83 (3H, m), 9.11 (1H, br s), 10.45 (2H, br s);
(9H, s), 5.13 (1H, t, J¼1.5 Hz), 7.11 (2H, dd, J¼1.5, 5.0 Hz), 7.20 (2H, d,
J¼1.6 Hz), 7.27 (2H, d, J¼1.4 Hz), 7.51 (4H, d, J¼8.5 Hz), 7.56 (4H, br
d, J¼6.8 Hz), 7.58–7.65 (6H, m), 7.69 (4H, d, J¼8.5 Hz), 7.80 (2H, dd,
J¼1.5, 5.0 Hz), 8.95 (1H, br s),10.36 (2H, br s); 13C NMR (TFA–CDCl3):
13C NMR (TFA–CDCl3):
d 94.4, 115.8, 129.5, 129.60, 129.62, 133.4,
133.9, 134.5, 134.6, 136.2, 136.4, 137.5, 137.9, 138.00, 138.05, 140.7,
144.3, 150.7, 152.1, 161.5; HRMS (EI), m/z calcd for C46H27Cl4N3þ2H:
763.1115. Found: 763.1120. Anal. calcd for C46H27Cl4N3.1/6CHCl3: C,
70.78; H, 3.49; N, 5.36. Found: C, 70.80; H, 3.36; N, 5.41.
d 30.7, 35.5, 91.1, 116.9, 129.1, 129.3, 129.6, 130.5, 132.8, 133.7, 133.8,
136.3, 136.5, 137.2, 137.9, 138.2, 139.9, 144.3, 150.1, 152.3, 156.9,
161.5; HRMS (EI), m/z calcd for C50H37Cl2N3þ2H: 751.2521. Found:
751.2526. Anal. calcd for C50H37Cl2N3: C, 79.99; H, 4.97; N, 5.60.
Found: C, 80.03; H, 4.75; N, 5.57.
4.2.9. 3-tert-Butyl-6,11,16,21-tetraphenylbenziporphyrin (8e). Pre-
pared by the foregoing procedure from dicarbinol 10c (346 mg,
1.00 mmol), benzaldehyde (205 mL, 2.00 mmol) and pyrrole (208 mL,
3.00 mmol). Recrystallization from chloroform–ligroin gave the
benziporphyrin (82.8 mg, 0.121 mmol, 12%) as green crystals, mp
>300 ꢁC; UV–vis (1% Et3N–CHCl3): lmax (log10 3) 418 (4.83), 690 (sh,
3.96), 729 nm (3.96); UV–vis (1% TFA–CHCl3): lmax (log10 3) 329
(4.52), 380 (4.46), 462 (5.04), 610 (3.88), 668 (3.82), 900 nm (4.19); 1H
4.2.12. 3-tert-Butyl-6,11,16,21-tetrakis(4-chlorophenyl)benzipor-
phyrin (8h). Prepared by the foregoing procedure from dicarbinol
10d (415 mg, 1.00 mmol), 4-chlorobenzaldehyde (281.2 mg,
2.00 mmol) and pyrrole (208 mL, 3.00 mmol). Recrystallization from
chloroform–ligroin gave the benziporphyrin (261.2 mg, 0.318 mmol,
32%) as dark green crystals, mp >300 ꢁC; UV–vis (1% Et3N–CHCl3):
lmax (log10 3) 420 (4.98), 691 (sh, 4.11), 738 nm (4.14); UV–vis (1%
TFA–CHCl3): lmax (log10 3) 331 (4.59), 391 (4.46), 469 (5.19), 627
NMR (500 MHz, CDCl3):
d
0.99 (9H, s), 6.56 (2H, d, J¼4.8 Hz), 6.78 (2H,
s), 7.04 (2H, d, J¼1.5 Hz), 7.05 (1H, t, J¼1.5 Hz), 7.24 (2H, d, J¼4.8 Hz),
(3.80), 668 (3.81), 900 nm (4.31); 1H NMR (500 MHz, CDCl3):
d 1.03
7.39–7.50 (20H, m), 10.14 (1H, br s); 1H NMR (500 MHz, TFA–CDCl3):
(9H, s), 6.56 (2H, d, J¼4.8 Hz), 6.77 (2H, s), 6.94 (1H, t, J¼1.6 Hz), 7.03
d
1.09 (9H, s), 5.05 (1H, t, J¼1.6 Hz), 7.12 (2H, dd, J¼1.5, 5.0 Hz), 7.21
(2H, d, J¼1.6 Hz), 7.22 (2H, d, J¼4.8 Hz), 7.35–7.47 (16H, m),10.07 (1H,
(2H, d, J¼1.5 Hz), 7.29 (2H, d, J¼1.4 Hz), 7.55–7.65 (14H, m), 7.72 (4H, t,
J¼7.7 Hz), 7.82 (2H, tt, J¼1.1, 7.4 Hz), 7.86 (2H, dd, J¼1.6, 5.0 Hz), 8.47
br s); 1H NMR (500 MHz, TFA–CDCl3):
d 1.12 (9H, s), 5.16 (1H, t,
J¼1.6 Hz), 7.11 (2H, dd, J¼1.5, 5.0 Hz), 7.20 (2H, d, J¼1.5 Hz), 7.26 (2H,
d, J¼1.5 Hz, partially obscured by solvent peak), 7.50 (8H, d,
J¼8.5 Hz), 7.59 (4H, d, J¼8.6 Hz), 7.70 (4H, d, J¼8.5 Hz), 7.81 (2H, dd,
J¼1.5, 5.0 Hz), 9.09 (1H, br s), 10.42 (2H, br s); 13C NMR (TFA–CDCl3):
(1H, br s), 10.14 (2H, br s); 13C NMR (CDCl3):
d 31.0, 34.7, 107.4, 115.0,
127.2, 127.5, 128.1, 128.4, 130.0, 130.5, 131.4, 132.5, 133.4, 136.5, 137.8,
140.0, 143.2, 145.4, 147.8, 151.1, 156.6, 171.8; 13C NMR (TFA–CDCl3):
d
30.6, 35.4, 91.3, 116.6, 129.0, 129.1, 129.3, 130.5, 133.2, 133.4, 133.6,
d 30.6, 35.5, 91.8, 115.6, 129.3, 129.5, 133.2, 133.7, 134.7, 134.8, 136.4,
133.8, 135.6, 136.4, 138.0, 138.1, 139.8, 144.2, 151.8, 152.5, 156.8, 161.3;
HRMS (EI), m/z calcd for C50H39N3þ2H: 683.3300. Found: 683.3302.
Anal. calcd for C50H39N3$1/5CHCl3: C, 85.43; H, 5.60; N, 5.95. Found: C,
85.60; H, 5.67; N, 5.97.
137.3, 137.5, 137.9, 138.0, 140.4, 144.3, 151.0, 152.1, 157.1, 161.2; HRMS
(EI), m/z calcd for C50H35Cl4N3þ2H: 819.1741. Found: 819.1743. Anal.
calcd for C50H35Cl4N3: C, 73.27; H, 4.30; N, 5.13. Found: C, 73.48; H,
4.18; N, 5.16.
4.2.10. 3-tert-Butyl-11,16-bis(4-chlorophenyl)-6,21-diphenylbenzi-
porphyrin (8f). Prepared by the foregoing procedure from dicarbinol
10c (346 mg, 1.00 mmol), 4-chlorobenzaldehyde (281.2 mg,
4.2.13. [3-tert-Butyl-6,11,16,21-tetraphenylbenziporphyrinato]-
palladium(II) (19a). Palladium(II) acetate (8.0 mg) and acetonitrile
(10 mL) were added to a solution of benziporphyrin 8e (20.0 mg,
0.029 mmol) in chloroform (10 mL), and the mixture was stirred
under reflux for 2 h. The solutionwas cooled, washed with water and
evaporated under reduced pressure. The residue was chromato-
graphed on grade 3 basic alumina, eluting with 50% dichloro-
methane–hexanes, and recrystallized from chloroform–methanol to
give the palladium complex (14.7 mg, 0.019 mmol, 65%) as deep
purple crystals, mp >300 ꢁC; UV–vis (CHCl3): lmax (log10 3) 341
2.00 mmol) and pyrrole (208 mL, 3.00 mmol). Recrystallization from
chloroform–ligroin gave the benziporphyrin (142.7 mg, 0.190 mmol,
19%) as dark green crystals, mp >300 ꢁC; UV–vis (1% Et3N–CHCl3):
lmax (log10 3) 419 (4.97), 685 (4.11), 729 nm (4.12); UV–vis (1% TFA–
CHCl3): lmax (log10 3) 327 (4.55), 386 (4.49), 464 (5.17), 619 (3.75), 663
(3.75), 900 nm (4.31); 1H NMR (500 MHz, CDCl3):
d
0.99 (9H, s), 6.54
(2H, d, J¼4.8 Hz), 6.77 (2H, s), 7.00 (1H, t, J¼1.6 Hz), 7.03 (2H, d,